Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life

Ousseny Zerbo; G. Thomas Ray; Bruce Fireman; Evan Layefsky; Kristin Goddard; Edwin Lewis; Pat Ross; Saad Omer; Mara Greenberg; Nicola P. Klein

doi:10.1038/s41467-023-36547-4

Nature Communications (Feb 2023)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life

Ousseny Zerbo,
G. Thomas Ray,
Bruce Fireman,
Evan Layefsky,
Kristin Goddard,
Edwin Lewis,
Pat Ross,
Saad Omer,
Mara Greenberg,
Nicola P. Klein

Affiliations

Ousseny Zerbo: Kaiser Permanente Northern California, Vaccine Study Center
G. Thomas Ray: Kaiser Permanente Northern California, Vaccine Study Center
Bruce Fireman: Kaiser Permanente Northern California, Vaccine Study Center
Evan Layefsky: Kaiser Permanente Northern California, Vaccine Study Center
Kristin Goddard: Kaiser Permanente Northern California, Vaccine Study Center
Edwin Lewis: Kaiser Permanente Northern California, Vaccine Study Center
Pat Ross: Kaiser Permanente Northern California, Vaccine Study Center
Saad Omer: Yale University, Institute for Global Health
Mara Greenberg: Obstetrics and Gynecology, Kaiser Permanente Northern California Oakland
Nicola P. Klein: Kaiser Permanente Northern California, Vaccine Study Center

DOI: https://doi.org/10.1038/s41467-023-36547-4
Journal volume & issue: Vol. 14, no. 1
pp. 1 – 8

Abstract

Read online

This study investigates the impact of maternal COVID-19 vaccination during pregnancy on infant infection during the first six months of life. Using data from California, USA, the authors find that protection against infection during the period of Delta dominance was high, but that it declined during the Omicron period.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal